Heow Tan
6Patents
3h-index
24Co-inventors
49Inventor score
Filing activity: Mar 3, 2016 → Jan 30, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9655857B2 | Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor | Human Necessities | 22 | Active |
| US10010507B1 | Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor | Human Necessities | 16 | Active |
| US10213386B2 | Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor | Human Necessities | 11 | Active |
| US10828259B2 | Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor | Human Necessities | 1 | Active |
| US12215113B2 | Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide] | Human Necessities | 0 | Active |
| US12018032B2 | Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.